European Science Foundation

By Julia Karow
In an effort to unravel the genetics of monogenic forms of epilepsy, a consortium of researchers in Europe has embarked on the Genetics of Rare Epilepsy Syndromes project.

Calling for greater funding from governments, academia, nonprofits, and the private sector, the report said "recent years have witnessed an unprecedented gain of knowledge from" RNA research, yet Europe has "only has a few centers specifically funded to RNA research."

The European Science Foundation said it envisions the institute consisting of locally-funded, multidisciplinary centers with research groups in disciplines, such as biology, biochemistry, chemistry, genetics, bioinformatics, biophysics, structural analysis, microbiology, plant sciences, and clinical medicine.

The BBSRC and EPSRC have granted over $2 million to support synthetic biology projects involving UK/Europe collaborations.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.